cysteine has been researched along with Neuroendocrine Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capriati, V; Dimiccoli, V; Mandracchia, D; Maqoud, F; Mele, A; Scilimati, A; Tolomeo, A; Trapani, A; Trapani, G; Tricarico, D; Vitale, P | 1 |
| Evan, G; Hanahan, D; Nozawa, H; Rostker, F; Shchors, K; Swigart-Brown, L; Xu, J | 1 |
2 other study(ies) available for cysteine and Neuroendocrine Tumors
| Article | Year |
|---|---|
A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease.
Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Neuroblastoma; Neuroendocrine Tumors; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar | 2017 |
Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis.
Topics: Animals; bcl-X Protein; Cathepsin B; CD11b Antigen; Cell Transformation, Neoplastic; Cysteine; Disease Models, Animal; GTPase-Activating Proteins; Inflammation; Interleukin-1beta; Leukocytes; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc | 2013 |